announced that GlaxoSmithKline (GSK) has decided to implement Medidata Designer, a study design optimization solution, for its Clinical Research and Development organization. Using Designer, GSK can consistently design studies that meet key objectives and collect necessary data in a streamlined and efficient manner. 

Medidata Designer drives study design quality with a CDISC-compliant data model that enforces the links across objectives, end points and procedures. This reusable metadata accelerates system setup, such as electronic data capture build, and automates the derivation of protocols and other key clinical deliverables. It improves compliance with standards, allows clinicians to focus on the science of clinical research and not on document management, and speeds study starts, shortening time to market for new therapies.